Praxis Precision Medicines Ownership | Who Owns Praxis Precision Medicines?


OverviewForecastRevenueFinancialsChartTranscripts

Praxis Precision Medicines Ownership Summary


Praxis Precision Medicines is owned by 34.56% institutional investors, 0.16% insiders, and 65.28% retail investors. Cormorant asset management, lp is the largest institutional shareholder, holding 8.29% of PRAX shares. American Funds SMALLCAP World A is the top mutual fund, with 3.71% of its assets in Praxis Precision Medicines shares.

PRAX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPraxis Precision Medicines34.56%0.16%65.28%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cormorant asset management, lp1.75M8.29%$66.08M
Blackrock funding, inc. /de1.46M7.74%$112.55M
Price t rowe associates inc /md/1.21M6.40%$93.01M
Vanguard group1.06M5.63%$81.86M
Soleus capital management1.14M5.41%$43.16M
Capital research global investors993.57K5.26%$76.47M
Janus henderson group929.52K4.92%$71.62M
Vr adviser989.99K4.70%$37.49M
Perceptive advisors980.89K4.66%$37.15M
Adage capital partners gp605.01K3.20%$46.56M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp185.00K7.21%$7.01M
72 investment65.93K7.02%$2.50M
Acuta capital partners67.50K5.23%$5.19M
Cormorant asset management, lp1.75M4.97%$66.08M
Vr adviser989.99K3.19%$37.49M
5am venture management170.00K3.12%$13.08M
Soleus capital management1.14M3.11%$43.16M
Ally bridge group (ny)44.98K2.97%$3.46M
Perceptive advisors980.89K1.31%$37.15M
Sphera funds management91.58K1.27%$7.05M

Top Buyers

HolderShares% AssetsChange
Soleus capital management1.14M3.11%896.20K
Deerfield management company, l.p. (series c)619.93K0.46%619.93K
Assenagon asset management559.08K0.07%548.99K
Janus henderson group929.52K0.04%405.96K
Driehaus capital management481.60K0.18%316.69K

Top Sellers

HolderShares% AssetsChange
Ra capital management---761.96K
Point72 asset management521.27K0.09%-511.97K
Perceptive advisors980.89K1.31%-348.84K
Kingdon capital management---303.00K
Adage capital partners gp605.01K0.08%-249.07K

New Positions

HolderShares% AssetsChangeValue
Deerfield management company, l.p. (series c)619.93K0.46%619.93K$23.48M
Alyeska investment group226.79K0.07%226.79K$17.45M
Sofinnova investments157.64K0.39%157.64K$5.97M
Ikarian capital145.50K0.68%145.50K$5.51M
Norges bank118.90K0.00%118.90K$9.15M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Parallel advisors-2.00
Assetmark-7.00
Lindbrook capital-11.00
Global retirement partners-14.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202516-90.86%7,276,078-66.50%340.26%10-89.47%3-94.12%
Dec 31, 202473-50.00%6,922,762-63.30%360.37%44-41.33%21-54.35%
Sep 30, 202414617.74%18,864,9992.39%991.04%75-8.54%4670.37%
Jun 30, 20241245.98%18,424,83215.78%970.75%82-5.75%2750.00%
Mar 31, 202411791.80%15,914,32798.53%1140.77%87625.00%18-61.70%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A748.24K3.71%-139.82K
Vanguard Total Stock Mkt Idx Inv562.19K2.76%-
Vanguard US Total Market Shares ETF541.27K2.68%-
iShares Russell 2000 ETF444.74K2.18%219.00
US Small-Cap Growth II Equity Comp388.78K1.93%-29.58K
T. Rowe Price New Horizons388.78K1.93%-5.26K
Renaissance Global Health Care388.36K1.91%-
SPDR® S&P Biotech ETF329.98K1.62%426.00
Vanguard Institutional Extnd Mkt Idx Tr269.90K1.32%445.00
T. Rowe Price Health Sciences216.02K1.07%-3.27K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 14, 2024Nemiroff Alex General Counsel and SecretarySell$660.83K
Nov 14, 2024Mastrocola Lauren Principal Accounting OfficerSell$424.32K
Oct 05, 2023DeSimone Jill-Buy$25.38K
Jun 27, 2023Souza Marcio Chief Executive OfficerBuy$10.59K
Mar 24, 2023Kelly Timothy Edwin Chief Financial OfficerBuy$7.00K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4-2
2024 Q3--
2024 Q2--
2024 Q1--

PRAX Ownership FAQ


Who Owns Praxis Precision Medicines?

Praxis Precision Medicines shareholders are primarily institutional investors at 34.56%, followed by 0.16% insiders and 65.28% retail investors. The average institutional ownership in Praxis Precision Medicines's industry, Biotech Stocks , is 63.96%, which Praxis Precision Medicines falls below.

Who owns the most shares of Praxis Precision Medicines?

Praxis Precision Medicines’s largest shareholders are Cormorant asset management, lp (1.74M shares, 8.29%), Blackrock funding, inc. /de (1.46M shares, 7.74%), and Price t rowe associates inc /md/ (1.21M shares, 6.40%). Together, they hold 22.43% of Praxis Precision Medicines’s total shares outstanding.

Does Blackrock own Praxis Precision Medicines?

BlackRock is not among the top 10 institutional shareholders of Praxis Precision Medicines.

Who is Praxis Precision Medicines’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Praxis Precision Medicines’s biggest shareholder by percentage of total assets invested, with 7.21% of its assets in 185K Praxis Precision Medicines shares, valued at 7.01M$.

Who is the top mutual fund holder of Praxis Precision Medicines shares?

American Funds SMALLCAP World A is the top mutual fund holder of Praxis Precision Medicines shares, with 3.71% of its total shares outstanding invested in 748.24K Praxis Precision Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools